Industry News
Biotechnology Industry News

PAQ Therapeutics emerges with $30M series A for autophagy-based treatments
PAQ Therapeutics emerges with $30M series A for autophagy-based treatments klahucik Wed, 07/14/2021 - 15:05
ACB hires Liu from Eureka Therapeutics to lead push into clinic
ACB hires Liu from Eureka Therapeutics to lead push into clinic ntaylor Wed, 07/14/2021 - 08:08
Ribon, backed by biopharma majors, raises $65M to take PARP7 inhibitor deeper into the clinic
Ribon, backed by biopharma majors, raises $65M to take PARP7 inhibitor deeper into the clinic ntaylor Wed, 07/14/2021 - 08:02
Eli Lilly’s $1B buyout bet for Protomer brings the ‘next frontier’ in smart insulin tech under the Big Pharma’s wing
Eli Lilly's $1B buyout bet for Protomer brings the 'next frontier' in smart insulin tech under the Big Pharma's wing badams Wed, 07/14/2021 - 07:51
Controlling Alzheimer’s by targeting immune signaling between brain cells
Controlling Alzheimer's by targeting immune signaling between brain cells aliu Wed, 07/14/2021 - 03:57
Ionis pays Bicycle $45M to expand oligonucleotide delivery toolkit
Ionis pays Bicycle $45M to expand oligonucleotide delivery toolkit ntaylor Tue, 07/13/2021 - 08:11
Nimbus raises $105M for multifront TYK2 clinical trial program
Nimbus raises $105M for multifront TYK2 clinical trial program ntaylor Tue, 07/13/2021 - 07:28
Biogen taps Chinese biotech InnoCare in $125M midstage MS drug pact
Biogen taps Chinese biotech InnoCare in $125M midstage MS drug pact badams Tue, 07/13/2021 - 03:37
Penn team uses CRISPR to edit out genetic disease before and after birth in mice
Penn team uses CRISPR to edit out genetic disease before and after birth in mice arlene.weintraub Mon, 07/12/2021 - 09:17
Poxel pivots to different programs, but questions abound over imeglimin
Poxel pivots to different programs, but questions abound over imeglimin ntaylor Mon, 07/12/2021 - 08:11
Novo Nordisk puts $1.2B on the table for Prothena’s ATTR drug, teeing up Alnylam challenge and cardiovascular expansion
Novo Nordisk puts $1.2B on the table for Prothena’s ATTR drug, teeing up Alnylam challenge and cardiovascular expansion ntaylor Mon, 07/12/2021 - 08:05
With targets lined up and a $106M raise this year, Tenaya Therapeutics decides now is the time to IPO
With targets lined up and a $106M raise this year, Tenaya Therapeutics decides now is the time to IPO badams Mon, 07/12/2021 - 03:59
FDA puts Sigilon’s hemophilia cell therapy trial on hold thanks to safety concerns
FDA puts Sigilon’s hemophilia cell therapy trial on hold thanks to safety concerns aalidrus Fri, 07/09/2021 - 11:10
J&J, Vor ally to assess bispecific and stem cell therapy in AML
J&J, Vor ally to assess bispecific and stem cell therapy in AML ntaylor Fri, 07/09/2021 - 07:42
U.K. regulator accepts Humanigen’s COVID drug for speedy review, as analysts spell out reasons to be hopeful for FDA nod
U.K. regulator accepts Humanigen's COVID drug for speedy review, as analysts spell out reasons to be hopeful for FDA nod badams Fri, 07/09/2021 - 07:33
U.K. regulator accepts Humanigen’s COVID drug for speedy review, as analysts spell out reasons to be hopeful for FDA nod
U.K. regulator accepts Humanigen's COVID drug for speedy review, as analysts spell out reasons to be hopeful for FDA nod badams Fri, 07/09/2021 - 07:33
Britain bets on biotech as billions set to boost life sciences sector
Britain bets on biotech as billions set to boost life sciences sector badams Thu, 07/08/2021 - 09:34
Muna raises $73M to go after Alzheimer’s, Parkinson’s and MS
Muna raises $73M to go after Alzheimer's, Parkinson's and MS ntaylor Thu, 07/08/2021 - 09:26
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides’ multiple myeloma drug
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides' multiple myeloma drug ntaylor Thu, 07/08/2021 - 07:55
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides’ multiple myeloma drug
Large differences in phase 3 overall survival spark FDA hold on Oncopeptides' multiple myeloma drug ntaylor Thu, 07/08/2021 - 07:55

